Previous business/academic article Next business/academic article
Academic Articles Awards > Intellectual Property

Product Hopping and the Limits of Antitrust: The Danger of Micromanaging Innovation

Douglas H. Ginsburg, Koren W. Wong-Ervin, & Joshua D. Wright, CPI Antitrust Chronicle (1), December 2015

See Joshua D. Wright's resume See Douglas H. Ginsburg's resume See Koren Wong-Ervin's resume

Vote for this articleHelp

* Average
** Interesting
*** Good
**** Excellent
***** Must receive an Award!

Please note that the star(s) appearing on the article page before you have voted reflect the status of all votes registered to date.

Readers’ vote will close on February 15, 2016. Readers’ vote will allow you to nominate 1 article for each of the Awards, i.e., 10 Academic articles, 10 Business articles, and the best Soft Laws. The readers’ short-list of Academic and Business Articles will be communicated to the Board together with the 20 articles nominated by the Steering Committees. The Board will decide on the award-winning articles. Results will be announced at the Awards ceremony to take place in Washington DC on the eve of the ABA Antitrust Spring Meeting on April 5, 2016.

In this article on product hopping, we explain that, considering the potential for significant consumer benefits from even small changes in product design, coupled with antitrust agencies and courts being ill-equipped to displace the judgments of consumers (and, with regard to drugs, their doctors) about the value of a new product design, product hopping should be per se lawful absent objective evidence that Product B is a sham innovation with zero or negative consumer welfare effects.

Download our brochure